Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600829)"HPGC Renmintongtai Pharmaceutical Corporation"Report for Q3 2026
Filed with SSE · Stock code 600829 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)HPGC Renmintongtai Pharmaceutical Corporation on 6ix
Earlier from HPGC Renmintongtai Pharmaceutical
- Announcement on Progress of Retrial of Major Litigation
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Resolutions of the 12th Meeting of the 11th Board of Directors
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Adjusting Members of Special Committees of the Board of Directors
Follow HPGC Renmintongtai Pharmaceutical into a list and get an email when it puts out news.
Follow HPGC Renmintongtai Pharmaceutical